郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways.

期刊:Biochemical pharmacology发表年份:2012作者:R A Bilardi; K-I Kimura; D R Phillips; S M Cutts

药效评价Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.

期刊:Journal of medicinal chemistry发表年份:2012作者:Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Andrei A Gakh; Fei Xu; Francesca Deflorian; Ruben Abagyan; Raymond C Stevens; Kenneth A Jacobson; Vsevolod Katritch

药效评价Long QT2 mutation on the Kv11.1 ion channel inhibits current activity by ablating a protein kinase Cα consensus site.

期刊:Molecular pharmacology发表年份:2012作者:Alexander J Donovan; Katherine Lansu; Jason G Williams; Mitchell F Denning; Saverio Gentile

药效评价Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.

期刊:Journal of medicinal chemistry发表年份:2012作者:Anatoly A Mazurov; Lan Miao; Balwinder S Bhatti; Jon-Paul Strachan; Srinivasa Akireddy; Srinivasa Murthy; David Kombo; Yun-de Xiao; Philip Hammond; Jenny Zhang; Terry A Hauser; Kristen G Jordan; Craig H Miller; Jason D Speake; Gregory J Gatto; Daniel